Pharmaceuticals buy - group a

Active Definitive Contract Awarded Last action

Contract number
75A50325C00014
Awardee
Awarding agency
Obligated
$493,619

Award facts

Opportunity
Contract value 21% obligated
  • $493,618.76 Current, with exercised options
  • $2,332,318.76 Potential, with all options
Completion date 23% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 12 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Sheridan, WY 82801, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00003 · The purpose of this modification is to exercise option period 1. $339,779
Change Order P00002 · To reduce the scope of contract for amoxicillin clavulanate acid -$134,976
Supplemental Agreement for work within scope P00001 · To change the NDC for amoxicillin clavulanate acid 500MG 125MG 100 tablets bottle from 6586201701 to 6586250220 $0
Original award Pharmaceuticals buy - group a albuterol nebulizer solution, amoxicillin/clavulanate, bactrim DS, penicillin, and voriconazole $288,816

About this award

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $2,332,318.76 definitive contract to Chaymaa Faour LLC for FDA-approved pharmaceuticals for the Strategic National Stockpile on September 1, 2025. The award exercises option period 1 and carries no set-aside.

The awardee is a woman-owned small business based in Sheridan, Wyoming. The originating solicitation (75A50325R00002), posted March 10, 2025 with a proposal due date of April 3, 2025, sought full and open competition for eight pharmaceutical products including Albuterol Nebulizer Solution, Amoxicillin/Clavulanate Acid tablets, Bactrim DS, Doxycycline suspension, Ondansetron HCL tablets, Penicillin G Potassium vials, Sodium Chloride solution, and Voriconazole tablets. Contractors were required to provide brand name or equal products and assume all labor, materials, supplies, facilities, equipment, and transportation for delivery. The NAICS code is 325412 (pharmaceutical preparation manufacturing).

Place of performance is Sheridan, Wyoming. The contract runs through August 31, 2030 and includes a base year and four optional ordering periods, with unit quantities ranging from 18,240 to 2,504,091 depending on the medication. Offerors must comply with Trade Agreement Act and Buy American Act regulations and provide detailed product information including National Drug Code, shelf life, and manufacturing origin.

Quick answers

Who was awarded contract 75A50325C00014?

75A50325C00014 was awarded to Chaymaa Faour LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 1, 2025.

How much is contract 75A50325C00014 worth?

The government has obligated $493,619 on 75A50325C00014. Its potential value, with all options, is $2,332,319.

Was contract 75A50325C00014 competed?

The extent of competition for 75A50325C00014 was full and open competition. The government received 12 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award